Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rebamipide as an Adjunct to Methotrexate in Active Rheumatoid Arthritis
NCT05166304Phase 2Completed
- Sponsor
- October 6 University
- Start
- Jan 2024
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rebamipide in rheumatoid arthritis (RA), sponsored by October 6 University. Started Jan 2024; status: completed.
02
Drugs
rebamipide
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT05166304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05166304.